Figure 1.

Disproportionality analysis for cardiac failure with 15 protein kinase inhibitors, showing the adjusted reporting odds ratios (aRORs) with confidence intervals and P‐values. aRORs were calculated in multivariate logistic regression, with adjustment for age, gender, drug–drug interactions, at‐risk comedications for cardiac failure, time since approval